Results 71 to 80 of about 3,331 (189)
Premenstrual syndrome: possibility of therapy [PDF]
Гинекология, 2014 Premenstrual syndrome includes more than 200 variety of symptoms and requires more detailed examination to rule out serious medical conditions. The problem of treatment of premenstrual syndrome to be a return of women of reproductive age to normal life ...
I A Kulikov, T V Ovsyannikova
doaj
Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy
, 2007 BACKGROUND: Primary aldosteronism is recognized as the most frequent cause of secondary hypertension. Screening for primary aldosteronism by determination of the aldosterone-to-renin ratio (ARR) is much more frequently performed in current practice ...
PIZZOLO, Francesca +3 more
core +1 more source
The efficacy of 17β-estradiol and low dosed drospirenone use in postmenopausal women (literature review) [PDF]
Гинекология, 2015 Vasomotor symptoms, including hot flushes (HF), are the most common symptoms of menopause, requiring treatment with estrogen and/or progestogen. Recent international guidelines recognize the need to use the lowest effective dose of hormone replacement ...
E N Andreeva +2 more
doaj
Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats
, 2007 OBJECTIVE: Drospirenone is the unique progestin derived from 17-spironolactone used for contraception and hormone therapy. Few data are available concerning the effects of drospirenone on the central nervous system and neuroendocrine milieu. The opioid
CASAROSA E +7 more
core
, 2020 Drospirenone, as a part of combined oral contraceptives, has an antiproliferative effect on hyperplastic processes in the organs of the female reproductive system. Individual selection of COCs taking into account the dose and properties of the gestagenic
Gasparyan S.A. +7 more
core +1 more source
Treatment of dermopathy in patients with polycystic ovary syndrome (clinical lecture)
Медицинский совет, 2015 The article summarizes the current aspects of the pathogenesis of PCOS and hyperandrogenism mechanisms. The treatment of dermopathy using COC and other androgen receptor blockers is substantiated.
M. A. Gevorkyan +2 more
doaj +1 more source
, 2017 The main objective of the present research work was to develop and validate a simple reversed-phase high performance liquid chromatography (RP-HPLC) stability-indicating method for the determination of synthetic progestin drospirenone.
Sirajunisa Talath*, Sunil Dhaneshwar
core +1 more source
Patient Preference and Adherence, 2009 Gloria Bachmann, Sharon KopaczWomen’s Health Institute, University of Medicine and Dentistry of New Jersey, USAAbstract: The combined oral contraceptive pill (COC) consisting of drospirenone 3 mg/ethinyl estradiol 20 µg (3 mg DRSP/20 &
Gloria Bachmann, Sharon Kopacz
doaj
ГинекологияBackground. An unfavorable bleeding pattern is a common reason for refusing to continue hormonal contraception. Aim. To evaluate the characteristics of uterine bleeding when using a new combined oral contraceptive (COC) containing estetrol and ...
Irina V. Kuznetsova +1 more
doaj +1 more source
Folate-containing antiandrogen oral contraceptives: dermatological aspects [PDF]
Гинекология, 2016 Examined are the biological effects of folic acid and pathological conditions developing in the case of folate deficiency. Particular attention is paid to the application of innovative dermatological aspects of oral contraceptives with antiandrogenic ...
S A Monakhov
doaj